[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69101651D1 - Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat. - Google Patents

Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat.

Info

Publication number
DE69101651D1
DE69101651D1 DE69101651T DE69101651T DE69101651D1 DE 69101651 D1 DE69101651 D1 DE 69101651D1 DE 69101651 T DE69101651 T DE 69101651T DE 69101651 T DE69101651 T DE 69101651T DE 69101651 D1 DE69101651 D1 DE 69101651D1
Authority
DE
Germany
Prior art keywords
combination
activity
pharmaceutical composition
azelaic
photoaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69101651T
Other languages
English (en)
Other versions
DE69101651T2 (de
Inventor
Ruggero Caputo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering SpA
Cilag SpA
Original Assignee
Schering SpA
Cilag SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering SpA, Cilag SpA filed Critical Schering SpA
Application granted granted Critical
Publication of DE69101651D1 publication Critical patent/DE69101651D1/de
Publication of DE69101651T2 publication Critical patent/DE69101651T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69101651T 1990-02-20 1991-02-12 Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat. Expired - Lifetime DE69101651T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT01942290A IT1242478B (it) 1990-02-20 1990-02-20 Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.

Publications (2)

Publication Number Publication Date
DE69101651D1 true DE69101651D1 (de) 1994-05-19
DE69101651T2 DE69101651T2 (de) 1994-08-11

Family

ID=11157744

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69101651T Expired - Lifetime DE69101651T2 (de) 1990-02-20 1991-02-12 Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat.

Country Status (14)

Country Link
EP (1) EP0443413B1 (de)
JP (1) JPH08239320A (de)
KR (1) KR910021235A (de)
AT (1) ATE104144T1 (de)
AU (1) AU7118091A (de)
CA (1) CA2036678A1 (de)
DE (1) DE69101651T2 (de)
DK (1) DK0443413T3 (de)
IE (1) IE910558A1 (de)
IL (1) IL97271A0 (de)
IT (1) IT1242478B (de)
NZ (1) NZ237137A (de)
PT (1) PT96814B (de)
ZA (1) ZA911222B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547989A (en) * 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
DE102006004804A1 (de) 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen
US20100273756A1 (en) * 2009-04-27 2010-10-28 Reza Babapour Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
WO2012053009A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions comprising skin whitening agents
WO2017019951A2 (en) 2015-07-30 2017-02-02 Curology, Inc. Compositions amd methods of treating acne and photoaging
AU2019312562B2 (en) 2018-07-30 2025-05-01 Curology, Inc. Compositions and methods of treating acne and photoaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE3623862A1 (de) * 1986-07-11 1988-01-21 Schering Ag Verwendung von dicarbonsaeuren mit 7 - 13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur topischen behandlung von rosazea
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤

Also Published As

Publication number Publication date
IT9019422A1 (it) 1991-08-21
CA2036678A1 (en) 1991-08-21
ZA911222B (en) 1991-11-27
IT1242478B (it) 1994-03-17
DK0443413T3 (da) 1994-07-25
PT96814B (pt) 1998-07-31
EP0443413B1 (de) 1994-04-13
ATE104144T1 (de) 1994-04-15
PT96814A (pt) 1991-10-31
IT9019422A0 (it) 1990-02-20
KR910021235A (ko) 1991-12-20
DE69101651T2 (de) 1994-08-11
IE910558A1 (en) 1991-08-28
IL97271A0 (en) 1992-05-25
AU7118091A (en) 1991-08-22
JPH08239320A (ja) 1996-09-17
EP0443413A1 (de) 1991-08-28
NZ237137A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
IT1105040B (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
DE69208503D1 (de) Mikroverkapseltes Sonnenschutzmittel, das Verfahren zur Herstellung, kosmetische und pharmazeutische Zubereitungen mit Mikrokapseln und Verwendung derselben
DE122007000080I2 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.
FR2544984B1 (fr) Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation
ATE183075T1 (de) Retinoid enthaltendes mittel
DE69101651D1 (de) Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat.
DE69825887D1 (de) Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
ATE141160T1 (de) Ein flurbiprofen enthaltendes akutarzneimittel und seine verwendung
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
ATE102019T1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
KR890003373A (ko) 수면장애 및 우울증 치료에 화합물의 이용
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69008762D1 (de) Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
DE69008761D1 (de) Retinsäureester von D-Desosamin, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
ATE122563T1 (de) Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
ATE108653T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels für die behandlung von knochenverletzungen.
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition